NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: NeuroOne's Fourth Quarter and Fiscal Year 2025 Financial Results Announcement
TL;DR
NeuroOne's upcoming earnings report offers investors early insight into financial performance and potential growth in neurological disorder treatments.
NeuroOne will release Q4 and fiscal year 2025 results on December 17, followed by an investor conference call with webcast access.
NeuroOne's work on neurological disorder treatments aims to improve patient outcomes and reduce healthcare costs for better quality of life.
NeuroOne develops minimally invasive EEG and ablation solutions for conditions like epilepsy and Parkinson's, potentially expanding to AI applications.
Found this article helpful?
Share it with your network and spread the knowledge!
NeuroOne Medical Technologies Corporation will release its financial results for the fiscal fourth quarter and year ended September 30, 2025, and host an investor conference call to discuss these results.
The financial results will be released before market open on Wednesday, December 17, 2025.
The investor conference call and webcast will take place at 8:30 a.m. Eastern time on Wednesday, December 17, 2025. Participants can join via phone using the provided dial-in numbers or through the webcast link.
You can participate by dialing 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) with participant access code 924910, or by accessing the webcast at the provided link. It's recommended to join at least five minutes before the start.
Management will discuss the company's fourth quarter and full fiscal year 2025 financial results, provide a corporate update, and conclude with a Q&A session for telephone participants.
Yes, a playback of the call will be available through Wednesday, December 31, 2025, via phone at 877-481-4010 (U.S.) or 919-882-2331 (international) using replay passcode 53302, or through the webcast replay link.
NeuroOne is a medical technology company focused on developing and commercializing minimally invasive and hi-definition solutions for EEG recording, stimulation, and ablation for patients with neurological disorders such as epilepsy, Parkinson's disease, and chronic pain.
For investor relations inquiries, contact MZ Group - MZ North America at NMTC@mzgroup.us. For general company information, visit www.nmtc1.com.
This announcement provides key financial performance data for NeuroOne's recent fiscal year and quarter, offering insights into the company's financial health and operational progress, which is important for investment decisions and understanding corporate direction.
Curated from NewMediaWire
